Similarly, we previously revealed that the genetic deletion of the Fasn gene suppresses carcinogenesis in mouse models of HCC [20,21] but is ineffective against murine intrahepatic cholangiocarcinoma development [51]. This evidence concerns the gene FASN and intrahepatic cholangiocarcinoma.